These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Monnier L; Colette C; Leiter L; Ceriello A; Hanefeld M; Owens D; Tajima N; Tuomiletho J; Davidson J; Diabetes Care; 2007 Jan; 30(1):185-6; author reply 187-8. PubMed ID: 17192363 [No Abstract] [Full Text] [Related]
4. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Hirsch IB; Brownlee M Diabetes Care; 2007 Jan; 30(1):186-7; author reply 188-9. PubMed ID: 17192365 [No Abstract] [Full Text] [Related]
5. Early vascular risk factor modification in type 1 diabetes. Perkins BA; Bril V N Engl J Med; 2005 Jan; 352(4):408-9. PubMed ID: 15673807 [No Abstract] [Full Text] [Related]
6. [Prognostic value of ECG in diabetes mellitus: the danger of "knowing too much"]. RodrÃguez-Padial L Rev Esp Cardiol; 2007 Oct; 60(10):1015-7. PubMed ID: 17953921 [No Abstract] [Full Text] [Related]
7. [Etiology of diabetic microangiopathy. Is the glucose level everything?]. Rosenlund BL Tidsskr Nor Laegeforen; 1994 Mar; 114(7):826-7. PubMed ID: 8009505 [No Abstract] [Full Text] [Related]
8. The case for blood glucose control. Genuth SM Adv Intern Med; 1995; 40():573-623. PubMed ID: 7747658 [No Abstract] [Full Text] [Related]
9. Symposium on treatment of diabetic complications. 5. Strict glycemic control and diabetic microvascular complications. Shichiri M Intern Med; 1997 Feb; 36(2):144-7. PubMed ID: 9099605 [No Abstract] [Full Text] [Related]
10. Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes. Teleb M; Popp Switzer M; Elhanafi S; Elfar A; San Juan ZT Curr Cardiol Rep; 2016 Mar; 18(3):29. PubMed ID: 26886228 [TBL] [Abstract][Full Text] [Related]
11. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus. Swidan SZ; Montgomery PA Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308 [TBL] [Abstract][Full Text] [Related]
12. Lessons from the Diabetes Control and Complications Trial. Santiago JV Diabetes; 1993 Nov; 42(11):1549-54. PubMed ID: 8405693 [No Abstract] [Full Text] [Related]
13. Insulin infusion in diabetic patients with acute myocardial infarction. Davey G; Mckeigue P BMJ; 1996 Sep; 313(7058):639-40. PubMed ID: 8811747 [No Abstract] [Full Text] [Related]
14. Toward risk factor control for all patients with diabetes. Whitehouse F Diabetes Care; 1992 Nov; 15(11):1818-20. PubMed ID: 1468321 [No Abstract] [Full Text] [Related]
15. [Strict control of blood glucose in diabetics: does it prevent the appearance of complications?]. Ryder E Invest Clin; 1993; 34(2):53-4. PubMed ID: 8123708 [No Abstract] [Full Text] [Related]
16. Mortality risk remains higher in individuals with type 1 diabetes: A population-based cohort study (the Ayrshire diabetes follow-up cohort [ADOC]). Collier A; Connelly PJ; Hair M; Cameron L; Ghosh S; Waugh N Diabetes Obes Metab; 2018 Aug; 20(8):1965-1971. PubMed ID: 29687581 [TBL] [Abstract][Full Text] [Related]
17. [Immunological aspects of diabetic angiopathies pathogenesis]. Galenok VA; Zhuk EA Ter Arkh; 1998; 70(10):5-10. PubMed ID: 9864794 [No Abstract] [Full Text] [Related]
18. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Reserach in Children Network (DirecNet) Study Group Diabetes Care; 2007 Jan; 30(1):185; author reply 187-9. PubMed ID: 17192364 [No Abstract] [Full Text] [Related]
19. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Service FJ; O'Brien PC Diabetes Care; 2007 Jan; 30(1):186; author reply 187-8. PubMed ID: 17192366 [No Abstract] [Full Text] [Related]